179 related articles for article (PubMed ID: 24145628)
1. Incidence and prevalence of episcleritis and scleritis in Northern California.
Honik G; Wong IG; Gritz DC
Cornea; 2013 Dec; 32(12):1562-6. PubMed ID: 24145628
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study.
Gritz DC; Wong IG
Ophthalmology; 2004 Mar; 111(3):491-500; discussion 500. PubMed ID: 15019324
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
[TBL] [Abstract][Full Text] [Related]
4. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study.
Homayounfar G; Nardone N; Borkar DS; Tham VM; Porco TC; Enanoria WT; Parker JV; Vinoya AC; Uchida A; Acharya NR
Am J Ophthalmol; 2013 Oct; 156(4):752-8. PubMed ID: 23891336
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of episcleritis and scleritis in urban Australia.
Thong LP; Rogers SL; Hart CT; Hall AJ; Lim LL
Clin Exp Ophthalmol; 2020 Aug; 48(6):757-766. PubMed ID: 32279425
[TBL] [Abstract][Full Text] [Related]
6. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis].
Zhou Y; Wang Z; Zhang Y; Sun X
Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Clinical Characteristics of Episcleritis and Scleritis in Olmsted County, Minnesota.
Xu TT; Reynolds MM; Hodge DO; Smith WM
Am J Ophthalmol; 2020 Sep; 217():317-324. PubMed ID: 32437669
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis.
Pimentel MA; Browne EN; Janardhana PM; Borkar DS; Tham VM; Uchida A; Vinoya AC; Acharya NR
JAMA Ophthalmol; 2016 Sep; 134(9):1001-6. PubMed ID: 27387135
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study.
Acharya NR; Tham VM; Esterberg E; Borkar DS; Parker JV; Vinoya AC; Uchida A
JAMA Ophthalmol; 2013 Nov; 131(11):1405-12. PubMed ID: 24008391
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study.
Homayounfar G; Borkar DS; Tham VM; Nardone N; Acharya NR
Ocul Immunol Inflamm; 2014 Oct; 22(5):403-4. PubMed ID: 24295070
[No Abstract] [Full Text] [Related]
11. Cuban Ocular Toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba.
Bustillo JL; Diaz JD; Pacheco IC; Gritz DC
Br J Ophthalmol; 2015 Mar; 99(3):382-6. PubMed ID: 25253767
[TBL] [Abstract][Full Text] [Related]
12. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.
Braithwaite T; Adderley NJ; Subramanian A; Galloway J; Kempen JH; Gokhale K; Cope AP; Dick AD; Nirantharakumar K; Denniston AK
Arthritis Rheumatol; 2021 Jul; 73(7):1267-1276. PubMed ID: 33728815
[TBL] [Abstract][Full Text] [Related]
15. Severity of episcleritis and systemic disease association.
Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
[TBL] [Abstract][Full Text] [Related]
16. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.
Zhang Y; Amin S; Lung KI; Seabury S; Rao N; Toy BC
PLoS One; 2020; 15(8):e0237995. PubMed ID: 32841267
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.
Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G
Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216
[TBL] [Abstract][Full Text] [Related]
18. [New clinical and epidemiologic aspects of episcleritis and scleritis].
Denk PO; Rohrbach JM; Thiel HJ; Zierhut M
Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment].
Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J
Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507
[TBL] [Abstract][Full Text] [Related]
20. Smoking delays the response to treatment in episcleritis and scleritis.
Boonman ZF; de Keizer RJ; Watson PG
Eye (Lond); 2005 Sep; 19(9):949-55. PubMed ID: 15543188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
